Biosynth

Staad, 30th October- We are pleased to announce the opening of Biosynth Biological Technology; a new cutting-edge facility at Lifebay in Suzhou, China.  Read the Full Press release here: https://lnkd.in/egUutXJv Our newest site contains state-of-the-art facilities including a Bio-laboratory, which enhances our capabilities for internal project development initiatives and material supply into the domestic Life Science market.     The official opening on Tuesday 29th October brought together local and national dignitaries, Life Science and Pharma customers, and partners of Biosynth as well as representatives of our Leadership Team and Board.  Speaking at the opening ceremony Dr. Thomas Eisele, Chief Operations Officer, announced, “We are thrilled to be formally opening Biosynth Biological Technology. This facility represents our dedication to innovation and excellence and adds a crucial production site for internal materials as well as acting as a distribution and handling hub for our customers in the region.” Philip Noone Alessandra Vismara #Biosynth #Lifebay #Pharma #Lifesciences #Opening #Biologics #Chemicals  Pictured left to right; Biosynth's Dr. Thomas Eisele; Matt Gunnison; Gu Hong Jian, Committee Member of the Wuzhong Economic Development Zone Party Work Committee and Deputy Director of the Management Committee; Alessandra Vismara, Biosynth General Manager; Gu Xiao Dong, Deputy Secretary of the Wuzhong District Committee and District Mayor; Sacha Bachmann, Consul General of Switzerland in Shanghai; ZhangHua Qian, Standing Committee Member of the Wuzhong District Committee, Deputy Secretary of the Economic Development Zone Party Work Committee, and Deputy Director of the Management Committee; Biosynth Board Member Nico Haller, Director at KKR and CCO Philip Noone.

Payloads are the key to future therapeutics. Dive into the world of targeted drug delivery with this blog exploring the evolution of payloads. From classic chemotherapy to innovative ADCs, PDCs, and beyond, we'll uncover the diverse categories of potent molecules, the intricacies of conjugation, and the latest research shaping the future of medicine. Join us in our latest blog to learn how payloads are revolutionizing the fight against disease.  https://lnkd.in/e4FfKadE   #biosynth #DrugDelivery #TargetedTherapy #Pharmacology #Biotechnology #DrugDevelopment #MedicinalChemistry #ADCs #PDCs

Researchers have discovered that vortioxetine, an FDA-approved antidepressant, shows potential in treating glioblastoma (GBM), a highly aggressive brain cancer. Since GBM treatments have remained largely unchanged for decades, repurposing existing drugs like vortioxetine offers a promising strategy to accelerate new therapies. Recent studies by ETH Zürich revealed vortioxetine’s promising effects on GBM cells, offering hope for improved patient outcomes. Biosynth offers a cost-effective solution for the large-scale production of vortioxetine, detailed in a recent patent: (https://lnkd.in/dPnQukPA). This efficient manufacturing process ensures the drug’s availability at an industrial scale, supporting its potential repurposing in oncology. Read more on our blog: https://lnkd.in/dAhQm8aT #Glioblastoma #DrugRepurposing #HealthcareInnovation #CancerResearch

Just over 2 weeks to go until MEDICA - Leading International Trade Fair in Dusseldorf from 11-14 November. As leading suppliers to the clinical and veterinary diagnostics industries, it is so important to us to talk to our customers to understand the next set of challenges they face in the development or long term production of the most sensitive, most specific and most relevant assays. We Develop and Supply: 🦠 Peptide and Protein Antigens  🩸 Antibodies and Sera 🩸 Controls and Disease State Plasma   🧫 Enzymes and Enzyme Substrates 🏥 Small Molecules for Diagnostics and Imaging 💚 Next Generation Ethical and Sustainable Replacement Reagents Come and visit us in Hall 3, Booth 3D66 and so we can find out how to help you meet your diagnostics supply needs for now, 2025, and beyond. Our CCO Philip Noone will be there with the team including Audrey Bradley, Dearbhla Kane, Jovita Sakalyte and Catie Barrett. #Biosynth #Medica #Biosynthverse #MedTech

#NationalPumpkinDay. Pumpkins have long been celebrated as a symbol of fall, with their vibrant orange hue adorning doorsteps and dinner tables. While pumpkins are famous for their role in festive decorations and comforting pies, they offer a surprising array of health benefits that extend well beyond their seasonal charm. Here, we explore their benefits, how pumpkins can contribute to your well-being, and the chemistry behind both these health features and the colors of some non-common species. #pumkins #chemistry #health

Biosynth is the ideal custom antibody manufacturing partner, with both the creativity to adapt to new situations and the set protocols and certifications (ISO9001, etc.) to ensure consistency of results. Our experience, mindset, and eagerness to learn allow us to efficiently sort through various solutions to arrive at the one that presents the best chances for success. Time and time again we have demonstrated our ability to solve our customer's most challenging custom antibody problems. From designing antibodies that can react to specific modifications when found on any protein (Wang, 2022), to collaborating with a leading biotech to produce antibodies to detect SARS-CoV-2 (Hällqvist, 2022), our custom antibody services are here to push your project to success. Read our slider below to find out how Biosynth excels in the comprehensive development of custom monoclonal and polyclonal antibodies for any purpose, including our expertise in antigen design. Visit our website for more information on our offering https://lnkd.in/en8wqWYZ #antibody #customantibodies #monoclonalantibodies #polyclonalantibodies #antigendesign #lifesciences #biologics

Our survival rides on the expansion and advancements of industrial processes, but at what cost to the environment? It is true that our vital industrial processes deposit harmful and toxic waste products into ecosystems and are a detriment to our planet's health. With the rise of industry and the likes of crude oil polluting our soils and waters, it is becoming the responsibility of scientists to find a sustainable solution. Industrial enzymes such as catalase, used in bioremediation processes and the recycling of dyes in the textile industry, could be the answer. Showing remarkable capabilities of degrading 'more than one million molecules of hydrogen peroxide a second' (Kaushal, 2018), the enzyme catalase demonstrates its environmentally friendly, industrial prowess. It has successful application in bioremediation, textiles, paper, food, and pharmaceutical industries as well as being an intriguing solution to environmental monitoring in sterile facilities, which is hampered by traces of hydrogen peroxide disinfectant. For this latter application, Biosynth has developed a powerful catalase enzyme called ECAT01™ with an innovative patented application, available to purchase from our research product catalog (EC179336). https://lnkd.in/e2zVn88v Read our article to discover how catalase offers itself as a solution to common industrial problems and the reasons why Biosynth's catalase ECAT01™ offers a safer and more effective solution to confirming sterility in labs. #catalase #enzymes #environmentalmonitoring #sterilefacilities #hydrogenperoxide #sustainability #bioremediation #textiles #food #pharmaceuticals #greenchemistry

Why should you swap your BSA for StabolyTM? What many scientists are not aware of, is that the IVD reagent market is beginning to offer animal-free raw materials that are just as effective as their predecessors. One such product is StabolyTM Biosynth's synthetic BSA replacement. In this blog we will investigate BSA's limitations and explore StabolyTM as being a world's first in animal-free assay reagents, offering itself as a sustainable product with an array of advantages such as standardization, reproducibility, regulatory compliance, and reduced risk of disease transmission. https://lnkd.in/eQi9bbC4 Take the step towards a more sustainable science and order your animal-free BSA alternative today https://lnkd.in/eiCjPMid #staboly #BSA #sustainability #diagnosticreagents #IVD #lifesciences #animalfree #diagnostics #scientificresearch 

The strain that the obesity epidemic has brought in Western countries is considerable. The prevalence of overweight people has created a threat to health services that incur high costs for treating weight-related conditions such as diabetes type II, hypertension, and cardiovascular disease. And with obesity on the rise scientists are looking to key appetite peptides to provide a therapeutic solution. Our slider aims to explore the role of appetite-regulating peptides in homeostatic hunger as well as hedonic hunger and to find out if peptides are a possible solution to end the current obesity epidemic. Biosynth is excelling in the peptide field, offering a range of catalog peptides and custom peptide services. We have a whole host of appetite-related peptides with the potential to end the obesity crisis. Browse our peptide catalog https://lnkd.in/eKC45HKm Or visit our custom peptide services webpage https://lnkd.in/dBc_HQFV #appetite #appetiteregulation #obesity #globalhealth #peptides #homeostasis #hemostatichunger #hedonichunger

Biosynth is empowering advancements in drug delivery and biomolecule analysis with our complete custom bioconjugation services. Our offering well and truly blurs the interface between chemistry and biology and spans the development of tailored PEGylated biomolecules and conjugate vaccines to crafting customized polymers, linker components and activated PEGs. Biosynth is your go-to for new and upcoming bioconjugate drugs, conjugate vaccines, and polymer innovations. Whether you need pharmaceuticals, excipients, or reagents for diagnostics, our bioconjugate services are perfect for you. Read our article to learn more about our comprehensive services and why bioconjugation is a necessity in scientific progression. Visit our bioconjugation webpage to discover our offering https://lnkd.in/ewhKUJ8H #bioconjugation #bioconjugates #conjugatevaccines #polymers #PEG #bioconjugatemanufacturing #pharmaceuticals #diagnostics